Iradimed (IRMD) Other financing activities (2015 - 2024)

Iradimed (IRMD) has 10 years of Other financing activities data on file, last reported at $25704.0 in Q4 2024.

• On a quarterly basis, Other financing activities fell 84.83% year-over-year to $25704.0 in Q4 2024; TTM through Dec 2024 was $195109.0, a 20.09% decrease from a year earlier, with the FY2024 full-year figure at $29000.0, down 83.59% from the prior year.
• Other financing activities for Q4 2024 stood at $25704.0, down from $169403.0 in the prior quarter.
• Over the last five years, Other financing activities for IRMD reached as high as $931732.0 in Q3 2020 and fell as low as $1.0 in Q2 2022.
• Historically, Other financing activities has averaged $191984.3 across 5 years, with a median of $67434.0 in 2021.
• Across the five-year window, Other financing activities tumbled 100.0% in 2022 and surged 16940200.0% in 2023, its largest moves.
• Year by year, Other financing activities stood at $931732.0 in 2020, then slumped by 42.3% to $537627.0 in 2021, then tumbled by 100.0% to $1.0 in 2022, then jumped by 16940200.0% to $169403.0 in 2023, then tumbled by 84.83% to $25704.0 in 2024.
• Per Business Quant data, the three most recent Other financing activities figures were $25704.0 in Q4 2024, $169403.0 in Q4 2023, and $2.0 in Q3 2023.